260 related articles for article (PubMed ID: 22910694)
1. A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer.
Fauci JM; Straughn JM; Ferrone S; Buchsbaum DJ
Gynecol Oncol; 2012 Nov; 127(2):420-5. PubMed ID: 22910694
[TBL] [Abstract][Full Text] [Related]
2. B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer.
Simon I; Zhuo S; Corral L; Diamandis EP; Sarno MJ; Wolfert RL; Kim NW
Cancer Res; 2006 Feb; 66(3):1570-5. PubMed ID: 16452214
[TBL] [Abstract][Full Text] [Related]
3. B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance.
Huang C; Zhou L; Chang X; Pang X; Zhang H; Zhang S
Oncol Rep; 2016 Apr; 35(4):2183-90. PubMed ID: 26848032
[TBL] [Abstract][Full Text] [Related]
4. The characteristic expression of B7-H3 and B7-H4 in liver biopsies from patients with HBV-related acute-on-chronic liver failure.
Guo G; Cao D; Xu H; Ruan Z; Fei L; Xie Z; Wu Y; Chen Y
Pathol Int; 2012 Oct; 62(10):665-74. PubMed ID: 23005593
[TBL] [Abstract][Full Text] [Related]
5. B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression.
Simon I; Katsaros D; Rigault de la Longrais I; Massobrio M; Scorilas A; Kim NW; Sarno MJ; Wolfert RL; Diamandis EP
Gynecol Oncol; 2007 Aug; 106(2):334-41. PubMed ID: 17498784
[TBL] [Abstract][Full Text] [Related]
6. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients.
Chen L; Xie Q; Wang Z; Shi L; Wu C; Jiang J
Oncotarget; 2016 Nov; 7(47):77237-77243. PubMed ID: 27764786
[TBL] [Abstract][Full Text] [Related]
7. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
8. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.
Brunner A; Hinterholzer S; Riss P; Heinze G; Brustmann H
Gynecol Oncol; 2012 Jan; 124(1):105-11. PubMed ID: 21982044
[TBL] [Abstract][Full Text] [Related]
9. B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response.
Quandt D; Fiedler E; Boettcher D; Marsch WCh; Seliger B
Clin Cancer Res; 2011 May; 17(10):3100-11. PubMed ID: 21378130
[TBL] [Abstract][Full Text] [Related]
10. The characteristic expression of B7-associated proteins in Langerhans cell sarcoma.
Li H; Wang C; Guo G; Gao C; Wu Y; Chen Y
Acta Histochem; 2012 Nov; 114(7):733-43. PubMed ID: 22305414
[TBL] [Abstract][Full Text] [Related]
11. B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration.
Zhao LW; Li C; Zhang RL; Xue HG; Zhang FX; Zhang F; Gai XD
Acta Histochem; 2014 Sep; 116(7):1163-8. PubMed ID: 25053455
[TBL] [Abstract][Full Text] [Related]
12. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
Salceda S; Tang T; Kmet M; Munteanu A; Ghosh M; Macina R; Liu W; Pilkington G; Papkoff J
Exp Cell Res; 2005 May; 306(1):128-41. PubMed ID: 15878339
[TBL] [Abstract][Full Text] [Related]
13. Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer.
Kreymborg K; Haak S; Murali R; Wei J; Waitz R; Gasteiger G; Savage PA; van den Brink MR; Allison JP
Cancer Immunol Res; 2015 Aug; 3(8):849-54. PubMed ID: 26122284
[TBL] [Abstract][Full Text] [Related]
14. B7-H4 expression in ovarian serous carcinoma: a study of 306 cases.
Liang L; Jiang Y; Chen JS; Niu N; Piao J; Ning J; Zu Y; Zhang J; Liu J
Hum Pathol; 2016 Nov; 57():1-6. PubMed ID: 27349304
[TBL] [Abstract][Full Text] [Related]
15. Isolation and Validation of Anti-B7-H4 scFvs from an Ovarian Cancer scFv Yeast-Display Library.
Dangaj D; Scholler N
Methods Mol Biol; 2015; 1319():37-49. PubMed ID: 26060068
[TBL] [Abstract][Full Text] [Related]
16. Increase of circulating B7-H4-expressing CD68+ macrophage correlated with clinical stage of lung carcinomas.
Chen C; Zhu YB; Shen Y; Zhu YH; Zhang XG; Huang JA
J Immunother; 2012 May; 35(4):354-8. PubMed ID: 22495393
[TBL] [Abstract][Full Text] [Related]
17. Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape.
Chen C; Qu QX; Shen Y; Mu CY; Zhu YB; Zhang XG; Huang JA
Cancer Lett; 2012 Apr; 317(1):99-105. PubMed ID: 22108530
[TBL] [Abstract][Full Text] [Related]
18. Expression of costimulatory molecule B7-H4 in human malignant tumors.
Zheng X; Li XD; Wu CP; Lu BF; Jiang JT
Onkologie; 2012; 35(11):700-5. PubMed ID: 23147549
[TBL] [Abstract][Full Text] [Related]
19. B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration.
Miyatake T; Tringler B; Liu W; Liu SH; Papkoff J; Enomoto T; Torkko KC; Dehn DL; Swisher A; Shroyer KR
Gynecol Oncol; 2007 Jul; 106(1):119-27. PubMed ID: 17509674
[TBL] [Abstract][Full Text] [Related]
20. Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.
Dangaj D; Lanitis E; Zhao A; Joshi S; Cheng Y; Sandaltzopoulos R; Ra HJ; Danet-Desnoyers G; Powell DJ; Scholler N
Cancer Res; 2013 Aug; 73(15):4820-9. PubMed ID: 23722540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]